文献
J-GLOBAL ID:202202230398664454
整理番号:22A1023893
黒色腫患者における潰瘍および免疫関連遺伝子に基づく予後モデルの確立と治療標的としてのEIF3Bの同定【JST・京大機械翻訳】
Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target
著者 (6件):
Wu Zhengquan
(1Walter Brendel Center for Experimental Medicine, University of Munich, Munich, Germany)
,
Wu Zhengquan
(2Department of Otorhinolaryngology, Head and Neck Surgery, University of Munich, Munich, Germany)
,
Lei Ke
(3Department of Dermatology, The Second People’s Hospital of Chengdu, Chengdu, China)
,
Xu Sheng
(4Patient Monitor and Life Supporting (PMLS), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Shenzhen, China)
,
He Jiali
(5Department of General Outpatient, Shen zhen Healthcare Committee Office, Shenzhen, China)
,
Shi Enxian
(2Department of Otorhinolaryngology, Head and Neck Surgery, University of Munich, Munich, Germany)
資料名:
Frontiers in Immunology (Web)
(Frontiers in Immunology (Web))
巻:
13
ページ:
824946
発行年:
2022年
JST資料番号:
U7074A
ISSN:
1664-3224
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)